Herrero Raquel, Sánchez Gema, Asensio Iris, López Eva, Ferruelo Antonio, Vaquero Javier, Moreno Laura, de Lorenzo Alba, Bañares Rafael, Lorente José A
Department of Critical Care Medicine, Hospital Universitario de Getafe, Madrid, Spain.
CIBER de Enfermedades Respiratorias, Instituto de Investigación Carlos III, Madrid, Spain.
Intensive Care Med Exp. 2020 Dec 18;8(Suppl 1):48. doi: 10.1186/s40635-020-00337-9.
Patients with liver diseases are at high risk for the development of acute respiratory distress syndrome (ARDS). The liver is an important organ that regulates a complex network of mediators and modulates organ interactions during inflammatory disorders. Liver function is increasingly recognized as a critical determinant of the pathogenesis and resolution of ARDS, significantly influencing the prognosis of these patients. The liver plays a central role in the synthesis of proteins, metabolism of toxins and drugs, and in the modulation of immunity and host defense. However, the tools for assessing liver function are limited in the clinical setting, and patients with liver diseases are frequently excluded from clinical studies of ARDS. Therefore, the mechanisms by which the liver participates in the pathogenesis of acute lung injury are not totally understood. Several functions of the liver, including endotoxin and bacterial clearance, release and clearance of pro-inflammatory cytokines and eicosanoids, and synthesis of acute-phase proteins can modulate lung injury in the setting of sepsis and other severe inflammatory diseases. In this review, we summarized clinical and experimental support for the notion that the liver critically regulates systemic and pulmonary responses following inflammatory insults. Although promoting inflammation can be detrimental in the context of acute lung injury, the liver response to an inflammatory insult is also pro-defense and pro-survival. A better understanding of the liver-lung axis will provide valuable insights into new diagnostic targets and therapeutic strategies for clinical intervention in patients with or at risk for ARDS.
肝病患者发生急性呼吸窘迫综合征(ARDS)的风险很高。肝脏是一个重要器官,在炎症性疾病期间调节复杂的介质网络并调节器官间的相互作用。肝功能越来越被认为是ARDS发病机制和转归的关键决定因素,对这些患者的预后有重大影响。肝脏在蛋白质合成、毒素和药物代谢以及免疫调节和宿主防御中发挥核心作用。然而,在临床环境中评估肝功能的工具有限,并且肝病患者经常被排除在ARDS的临床研究之外。因此,肝脏参与急性肺损伤发病机制的具体机制尚未完全明确。肝脏的多种功能,包括内毒素和细菌清除、促炎细胞因子和类花生酸的释放和清除以及急性期蛋白的合成,可在脓毒症和其他严重炎症性疾病中调节肺损伤。在本综述中,我们总结了临床和实验证据,支持肝脏在炎症刺激后对全身和肺部反应起关键调节作用这一观点。虽然在急性肺损伤的情况下促进炎症可能有害,但肝脏对炎症刺激的反应也具有促防御和促生存的作用。更好地理解肝肺轴将为ARDS患者或有ARDS风险的患者的临床干预提供有关新诊断靶点和治疗策略的宝贵见解。